Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.

<h4>Background</h4>Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induced antibody level wanes over time. Peak vaccine-induced anti-HBs level is directly related to antibody decay, as well as risk of infection and persistent carriage despite...

Full description

Saved in:
Bibliographic Details
Main Authors: Branwen J Hennig, Katherine Fielding, John Broxholme, Mathurin Diatta, Maimuna Mendy, Catrin Moore, Andrew J Pollard, Pura Rayco-Solon, Giorgio Sirugo, Marianne A van der Sande, Pauline Waight, Hilton C Whittle, Syed M Zaman, Adrian V Hill, Andrew J Hall
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-03-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0001898&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850183408449224704
author Branwen J Hennig
Katherine Fielding
John Broxholme
Mathurin Diatta
Maimuna Mendy
Catrin Moore
Andrew J Pollard
Pura Rayco-Solon
Giorgio Sirugo
Marianne A van der Sande
Pauline Waight
Hilton C Whittle
Syed M Zaman
Adrian V Hill
Andrew J Hall
author_facet Branwen J Hennig
Katherine Fielding
John Broxholme
Mathurin Diatta
Maimuna Mendy
Catrin Moore
Andrew J Pollard
Pura Rayco-Solon
Giorgio Sirugo
Marianne A van der Sande
Pauline Waight
Hilton C Whittle
Syed M Zaman
Adrian V Hill
Andrew J Hall
author_sort Branwen J Hennig
collection DOAJ
description <h4>Background</h4>Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induced antibody level wanes over time. Peak vaccine-induced anti-HBs level is directly related to antibody decay, as well as risk of infection and persistent carriage despite vaccination. We investigated the role of host genetic factors in long-term immunity against HBV infection based on peak anti-HBs level and seroconversion to anti-HBc.<h4>Methods</h4>We analyzed 715 SNP across 133 candidate genes in 662 infant vaccinees from The Gambia, assessing peak vaccine-induced anti-HBs level and core antibody (anti-HBc) status, whilst adjusting for covariates. A replication study comprised 43 SNPs in a further 393 individuals.<h4>Results</h4>In our initial screen we found variation in IFNG, MAPK8, and IL10RA to affect peak anti-HBs level (GMTratio of < 0.6 or > 1.5 and P < or = 0.001) and lesser associations in other genes. Odds of core-conversion was associated with variation in CD163. A coding change in ITGAL (R719V) with likely functional relevance showed evidence of association with increased peak anti-HBs level in both screens (1st screen: s595_22 GMTratio 1.71, P = 0.013; 2nd screen: s595_22 GMTratio 2.15, P = 0.011).<h4>Conclusion</h4>This is to our knowledge the largest study to date assessing genetic determinants of HBV vaccine-induced immunity. We report on associations with anti-HBs level, which is directly related to durability of antibody level and predictive of vaccine efficacy long-term. A coding change in ITGAL, which plays a central role in immune cell interaction, was shown to exert beneficial effects on induction of peak antibody level in response to HBV vaccination. Variation in this gene does not appear to have been studied in relation to immune responses to viral or vaccine challenges previously. Our findings suggest that genetic variation in loci other than the HLA region affect immunity induced by HBV vaccination.
format Article
id doaj-art-cb6bc1b5abbb4ddb99e13482b8b7d393
institution OA Journals
issn 1932-6203
language English
publishDate 2008-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-cb6bc1b5abbb4ddb99e13482b8b7d3932025-08-20T02:17:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032008-03-0133e189810.1371/journal.pone.0001898Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.Branwen J HennigKatherine FieldingJohn BroxholmeMathurin DiattaMaimuna MendyCatrin MooreAndrew J PollardPura Rayco-SolonGiorgio SirugoMarianne A van der SandePauline WaightHilton C WhittleSyed M ZamanAdrian V HillAndrew J Hall<h4>Background</h4>Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induced antibody level wanes over time. Peak vaccine-induced anti-HBs level is directly related to antibody decay, as well as risk of infection and persistent carriage despite vaccination. We investigated the role of host genetic factors in long-term immunity against HBV infection based on peak anti-HBs level and seroconversion to anti-HBc.<h4>Methods</h4>We analyzed 715 SNP across 133 candidate genes in 662 infant vaccinees from The Gambia, assessing peak vaccine-induced anti-HBs level and core antibody (anti-HBc) status, whilst adjusting for covariates. A replication study comprised 43 SNPs in a further 393 individuals.<h4>Results</h4>In our initial screen we found variation in IFNG, MAPK8, and IL10RA to affect peak anti-HBs level (GMTratio of < 0.6 or > 1.5 and P < or = 0.001) and lesser associations in other genes. Odds of core-conversion was associated with variation in CD163. A coding change in ITGAL (R719V) with likely functional relevance showed evidence of association with increased peak anti-HBs level in both screens (1st screen: s595_22 GMTratio 1.71, P = 0.013; 2nd screen: s595_22 GMTratio 2.15, P = 0.011).<h4>Conclusion</h4>This is to our knowledge the largest study to date assessing genetic determinants of HBV vaccine-induced immunity. We report on associations with anti-HBs level, which is directly related to durability of antibody level and predictive of vaccine efficacy long-term. A coding change in ITGAL, which plays a central role in immune cell interaction, was shown to exert beneficial effects on induction of peak antibody level in response to HBV vaccination. Variation in this gene does not appear to have been studied in relation to immune responses to viral or vaccine challenges previously. Our findings suggest that genetic variation in loci other than the HLA region affect immunity induced by HBV vaccination.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0001898&type=printable
spellingShingle Branwen J Hennig
Katherine Fielding
John Broxholme
Mathurin Diatta
Maimuna Mendy
Catrin Moore
Andrew J Pollard
Pura Rayco-Solon
Giorgio Sirugo
Marianne A van der Sande
Pauline Waight
Hilton C Whittle
Syed M Zaman
Adrian V Hill
Andrew J Hall
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
PLoS ONE
title Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
title_full Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
title_fullStr Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
title_full_unstemmed Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
title_short Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
title_sort host genetic factors and vaccine induced immunity to hepatitis b virus infection
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0001898&type=printable
work_keys_str_mv AT branwenjhennig hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT katherinefielding hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT johnbroxholme hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT mathurindiatta hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT maimunamendy hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT catrinmoore hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT andrewjpollard hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT puraraycosolon hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT giorgiosirugo hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT marianneavandersande hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT paulinewaight hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT hiltoncwhittle hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT syedmzaman hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT adrianvhill hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection
AT andrewjhall hostgeneticfactorsandvaccineinducedimmunitytohepatitisbvirusinfection